Ranbaxy Laboratories is in speaks with Ind-Swift Labs

Indian medicine manufacturer Ranbaxy Laboratories is in speaks with Ind-Swift Labs to source ingredient to produce a generic version of Pfizer Inc.’s (PFE) Lipitor blood cholesterol medicine.

Ind-Swift vice chairman N. R. Munjal stated that the firm is talking about various choices to deliver intermediate or final active pharmaceutical raw materials atorvastatin to Ranbaxy.

Ranbaxy plans to release the cholesterol medicine in the United states. at the end of November, but regulatory and producing issues at the Indian firm have late FDA authorization for the medicine.

Be Sociable, Share!
Tags: ,

Stock Market Basics For Beginners

How To Make Profit From Market Corrections

How To Make Profit From Market Corrections The term "market correction" can instill fear into some stock market investors. For others, a correction means fresh share buying opportunities. Correction is a realistic scenario ...…

Advance Decline Index

Advance Decline Index A helpful instrument for discovering trend (bullish or bearish) in the share market  in which one divides the number of traded stocks that have increased ...…

Why does Securities Market require Regulators?

Why does Securities Market require Regulators? The lack of conditions of best competitors in the securities market creates the position of the Regulator very important. The regulator makes sure that the ...…

Longterm Investment Options

Longterm Investment Options Public Provident Fund, Post Office Savings Schemes, Company Fixed Deposits,  Mutual Funds, Debentures and Bonds are the best long term investment options for more details click ...…

Definition for Share

Definition for Share The Certificates representing one unit of ownership in a mutual fund, corporation and limited partnership, the share has a certain declared face value, ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics